Priority Date: 26.05.10 (US 20100348584P)

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF PRIMARY INSULIN-LIKE GROWTH FACTOR DEFICIENCY (PIGFD) AND IDIOPATHIC SHORT STATURE (ISS)

  • Application ID: EP11787424
  • Status: APPLICATION WITHDRAWN

Attorney

operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Mewburn Ellis LLP is specialized in C12. Mewburn Ellis LLP is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 26.05.2010 - Priority Date (US 20100348584P)
  • 01.12.2011 - Publication A1 (WO2011150228)
  • 10.04.2013 - Publication A1 (EP2576834)

IPC Classification